MCL1 and thyroid cancer: We evaluated the association between dinaciclib sensitivity and basal Mcl-1 and Bcl-xL levels as well as the ratio of Mcl-1:Bcl-xL in thyroid cancer cell lines (S8A Fig), and found no significant correlation (S8B Fig).